CEO Series - Shaping The Future of Healthcare with Andrew Barnett, Representative Director and President, AstraZeneca Japan

As one of the world’s most rapidly aging societies, Japan stands at the frontier of healthcare innovation. Complex healthcare challenges arise from this demographic shift, yet the country brings extraordinary strengths to the biopharmaceutical industry: world-class research and development, sophisticated health systems, and a steadfast commitment to improving patient outcomes.

For industry leaders, Japan is more than a major market; it is a place where challenge and capability come together to shape the future of medicine.

Join us for an inspiring evening with Andrew Barnett, Representative Director and President of AstraZeneca Japan, as part of our CEO Series. Drawing on his international leadership journey, Barnett will share what it takes to lead a global healthcare company in Japan and why the country remains a vital place in the future of medicine. This is a rare opportunity to hear directly from one of the sector’s most experienced global leaders on how science and patient-focused leadership can drive healthcare innovation.

Event Details:

• Date: Tuesday, October 20, 2026
• Time: 18:30-20:30
• Speaker: Andrew Barnett, Representative Director and President, AstraZeneca Japan
• Venue: AstraZeneca, Grand Front Osaka Tower B 19F
• Admission: Members: ¥4,000 | Non-Members: ¥5,000
• Registration/Cancellation Deadline: Tuesday, October 13 (17:00)

Supporting Organizations: British Chamber of Commerce in Japan and Canadian Chamber of Commerce in Japan

About the Speaker
A seasoned global healthcare leader, Andrew Barnett brings extensive leadership experience spanning more than two decades across commercial strategy, operational innovation, investor relations, and general management. He currently serves as Senior Vice President, Representative Director and President of AstraZeneca Japan. Prior to this role, he was Global Head of Investor Relations and led several global oncology franchises. Before joining AstraZeneca Japan in 2019, Barnett held senior leadership roles at Roche across three continents. He holds a bachelor of science degree in biochemistry from McGill University.

The event will be conducted in English with AI-powered Japanese translation.
※ 当イベントは英語で実施され、日本語へのAI翻訳が提供されます。

NOTE 1: This event is ON THE RECORD.

NOTE 2: Please note that, as with all guest presentations, the content and comments of the speakers reflect their own opinions and do not necessarily represent the opinions or policies of the ACCJ.

NOTE 3: Registration is on a first-come, first-served basis, and spots may be filled before the registration deadline. We recommend registering early to secure your place.

NOTE 4: If you cancel after the stated deadline, the full meeting fee will be charged to your account. No substitutions or walk-ins.